Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)
A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
desidadda
(22.53)
Submitted: 12/21/2011 9:44:41 PM :
Start Price:
$29.91
RDY Score:
+0.42
Generics rock
Recs
Omen1618
(< 20)
Submitted: 10/21/2011 10:57:19 AM :
Start Price:
$31.50
RDY Score:
-5.85
This company makes generic pharmaceuticals, ton of pharma patents coming due in the near future which provides DRL with a big upside.
Recs
dnelyo
(< 20)
Submitted: 9/10/2011 6:45:58 PM :
Start Price:
$30.49
RDY Score:
-11.21
India + pharmaceuticals = general guess into demographic growth & spending
Recs
rwpaules
(96.11)
Submitted: 6/16/2011 4:40:35 PM :
Start Price:
$34.32
RDY Score:
+10.71
Major FDA compliance issues going on in this company that will be costly to correct if they want to maintain access to the US market. See warning letter here:
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm258679.htm
Recs
1derway
(< 20)
Submitted: 5/27/2011 2:24:54 PM :
Start Price:
$35.01
RDY Score:
-8.18
I always buy generics! What a great company!
next 5 years eps growth 56%
peg .46!!!
Hello!
Recs
HardnoseDotCom
(73.69)
Submitted: 4/25/2011 1:31:30 PM :
Start Price:
$37.04
RDY Score:
-13.17
low PEG, strong price uptrend
Recs
frederick7
(< 20)
Submitted: 2/23/2011 12:38:15 PM :
Start Price:
$33.54
RDY Score:
-6.25
Big money!
Recs
istraveler
(< 20)
Submitted: 12/29/2010 1:37:53 AM :
Start Price:
$34.24
RDY Score:
-9.75
generic drugs + 7 Billion worldwide population = mega trend upside potential.
Recs
modestus1
(< 20)
Submitted: 12/27/2010 10:49:56 PM :
Start Price:
$36.41
RDY Score:
-17.82
One of India's leading generic drug maker with a large market to expand.
Recs
wombataholic
(< 20)
Submitted: 12/10/2010 4:34:33 PM :
Start Price:
$39.12
RDY Score:
+24.71
Grossly overpriced.
Recs
dgoldenz
(20.01)
Submitted: 11/8/2010 10:35:58 AM :
Start Price:
$39.29
RDY Score:
-27.54
up, up, and away
Recs
rogervictor
(< 20)
Submitted: 10/26/2010 2:16:46 PM :
Start Price:
$36.97
RDY Score:
-25.90
With the expiration of expensive patten, generic drug manufacturers are bound to prosper. TEVA, andReddy could be the next beneficiaries.
Recs
msricekc
(76.92)
Submitted: 10/13/2010 11:37:57 AM :
Start Price:
$13.76
RDY Score:
+126.84
I sold too early.
Recs
jimrusch22
(91.33)
Submitted: 7/26/2010 3:53:37 PM :
Start Price:
$27.39
RDY Score:
-2.21
rapidy growing globally - as aggressivie a company as TEVA
Recs
AmericanGenius
(< 20)
Submitted: 6/4/2010 11:44:38 AM :
Start Price:
$29.35
RDY Score:
-13.52
India or Pharm? How about both!
Recs
LevGross
(36.40)
Submitted: 5/28/2010 9:53:01 AM :
Start Price:
$28.19
RDY Score:
-6.96
Really like this company. Major player in generics in the US and positioned in the country with the biggest growth potential. Buy this and ABB.
Recs
sanjay1969
(< 20)
Submitted: 5/28/2010 6:25:10 AM :
Start Price:
$28.10
RDY Score:
-6.26
regarding hydrocarbon industry
Recs
tytymhorau
(39.33)
Submitted: 5/16/2010 4:09:09 PM :
Start Price:
$27.37
RDY Score:
-0.28
India-based mid-cap pharmaceutical company - a global provider of generic drugs and related active ingredients. Poised to profit from an increasing pipeline of drugs coming off patent, the insurance industry's increasing push toward generics in developed countries, and the cost effectiveness of generics for expanding health care in developing countries.
Recs
NHWeston
(77.46)
Submitted: 4/2/2010 12:09:39 PM :
Start Price:
$28.31
RDY Score:
+0.72
Dr. Reddy's is a rapidly growing player in the global generics market. For now, they virtually own their domestic market in India and, although overshadowed by more flashy companies like Teva, they are gaining market share in Europe and Latin America. Less celebrated but also important is - or so I'm told - they're doing some interesting original work in melanoma, diabetes, and cholera. I've also heard talk that they might be a t6ake-over candidate although the New Delhi government would pose an obstale here. 35 by Christmas. Regards.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 79 : 1 2 3 4 Next »